AE

Andreas Evers

SA Sanofi: 11 patents #1 of 232Top 1%
Overall (2017): #6,367 of 506,227Top 2%
11
Patents 2017

Issued Patents 2017

Patent #TitleCo-InventorsDate
9834527 Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals Christopher Kallus, Michael Wagner, Hermut Wehlan 2017-12-05
9789165 Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists Dieter Kadereit, Katrin Lorenz, Torsten Haack, Michael Wagner, Bernd Henkel +2 more 2017-10-17
9775904 Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists Martin Bossart, Ralf Elvert, Torsten Haack, Siegfried Stengelin, Michael Wagner 2017-10-03
9771406 Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 Martin Bossart, Ralf Elvert, Torsten Haack, Siegfried Stengelin, Michael Wagner +1 more 2017-09-26
9758561 Dual GLP-1/glucagon receptor agonists derived from exendin-4 Martin Bossart, Ralf Elvert, Torsten Haack, Siegfried Stengelin, Michael Wagner +1 more 2017-09-12
9751926 Dual GLP-1/GIP receptor agonists Dieter Kadereit, Katrin Lorenz, Torsten Haack, Michael Wagner, Bernd Henkel +2 more 2017-09-05
9750788 Non-acylated exendin-4 peptide analogues Dieter Kadereit, Katrin Lorenz, Torsten Haack, Michael Wagner, Bernd Henkel +2 more 2017-09-05
9745360 Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Martin Lorenz +1 more 2017-08-29
9694053 Dual GLP-1/glucagon receptor agonists Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Martin Bossart +1 more 2017-07-04
9688645 Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Christopher Kallus, Mark Broenstrup, Anja Globisch, Herman Schreuder, Michael Wagner 2017-06-27
9670261 Functionalized exendin-4 derivatives Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Martin Lorenz +1 more 2017-06-06